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Summary
Purpose:  Magnetic  resonance  imaging  (MRI)  is  the  investigation  of  choice  for  detecting  structural
lesions that  underlie  and  may  accompany  epilepsy.  Despite  advances  in  imaging  technology,
20—30% of  patients  with  refractory  focal  epilepsy  have  normal  MRI  scans.  We  evaluated  the
role of  repeated  imaging  with  improved  MRI  technology  —  an  increase  in  ﬁeld  strength  from
1.5 T  to  3  T  and  superior  head  coils  —  in  detecting  pathology  not  previously  seen.
Methods:  Retrospective  review  of  a  large  cohort  of  patients  attending  a  tertiary  epilepsy  refer-
ral centre  who  underwent  MRI  at  1.5  T  (1995—2004)  and  subsequently  3  T  (2004—2011)  with
improved head  coils.  Scan  reports  were  reviewed  for  the  diagnoses  and  medical  notes  for  the
epilepsy  classiﬁcation.
Results:  804  patients  underwent  imaging  on  both  scanners,  the  majority  with  focal  epilepsy
(87%). On  repeat  scanning  at  3  T,  37%  of  scans  were  normal  and  20%  showed  incidental  ﬁndings.
Positive ﬁndings  included  hippocampal  sclerosis  (13%),  malformations  of  cortical  development
(8%), other  abnormalities  (4%)  and  previous  surgery  (18%).  A  total  of  37  (5%)  relevant  new
diagnoses  were  made  on  the  3  T  scans  not  previously  seen  at  1.5  T.  The  most  common  new
ﬁndings were  hippocampal  sclerosis,  focal  cortical  dysplasia  and  dysembryoplastic  neuroepi-
thelial tumour.  These  ﬁndings  affected  patient  management  with  several  patients  undergoing
neurosurgery.
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Conclusions:  The  higher  ﬁeld  strength  and  improved  head  coils  were  associated  with  a  clinically
relevant increased  diagnostic  yield  from  MRI.  This  highlights  the  importance  of  technological
advances  and  suggests  that  rescanning  patients  with  focal  epilepsy  and  previously  negative  scans
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direct  relevance  in  37  patients  (5%,  Figs.  1—3),  particularly
hippocampal  sclerosis,  focal  cortical  dysplasia  and  dysem-
bryoplastic  neuroepithelial  tumour  (DNET).is clinically  beneﬁcial.
© 2013  The  Authors..  Publish
ntroduction
pilepsy  has  a  prevalence  of  approximately  1%  (Sander  and
horvon,  1996).  Over  half  have  focal  epilepsy  and  around
ne-third  are  refractory  to  medical  treatment  (Semah  and
yvlin,  2005).  Magnetic  resonance  imaging  (MRI)  is  the
maging  modality  of  choice  to  detect  possible  structural
esions  underlying  the  epilepsy,  to  assess  comorbidities  and
o  evaluate  individuals  with  medically  refractory  epilepsy
or  potential  surgery.  UK  guidelines  recommend  MRI  in  all
atients  with  epilepsy,  except  those  children  and  young  per-
ons  with  idiopathic  generalised  epilepsy  who  respond  to
rug  treatment  (National  Institute  for  Health  and  Clinical
xcellence,  2012).
Identiﬁcation  of  a  lesion  is  crucial  for  the  consideration  of
urgical  treatment  and  is  associated  with  a  greater  chance
f  seizure  freedom  following  surgery  (Kuzniecky  et  al.,  1993;
osewich  et  al.,  2000).  In  hippocampal  sclerosis,  co-existent
bnormalities  (‘‘dual  pathology’’)  are  common,  affecting
5%  of  adults  and  up  to  67%  of  children  (Bocti  et  al.,  2003).
orrect  recognition  of  abnormalities  inﬂuences  manage-
ent  and  prognosis.
Despite  advances  in  imaging  technology,  around  20—30%
f  patients  with  refractory  focal  epilepsy  have  normal  MRI
cans  (‘‘MRI-negative’’)  (Duncan,  2010).  It  is  widely  held
hat  an  increase  in  ﬁeld  strength  from  1.5  T  to  3  T  is  asso-
iated  with  greater  sensitivity  for  the  detection  of  lesions.
owever,  comparisons  of  imaging  in  patients  with  epilepsy
t  different  ﬁeld  strengths  are  limited  to  small  series  of
atients  being  considered  for  surgery  and  are  not  unanimous
n  their  conclusions.  In  a  series  of  40  patients  undergoing
urgical  evaluation,  3  T  MRI  identiﬁed  a  lesion  in  65%  of
he  patients  considered  MRI  negative  at  1.5  T  (Knake  et  al.,
005).  In  contrast  another  study  of  37  patients  undergoing
urgical  evaluation  failed  to  demonstrate  any  superiority  of
 T  MRI  over  1.5  T  MRI  (Zijlmans  et  al.,  2009).  Other  techno-
ogical  developments,  in  particular  changes  in  the  design  of
ead  coils  and  gradients,  may  contribute  but  have  not  been
ssessed  in  patients  with  epilepsy.
The  present  study  presents  a  retrospective  review  of  a
arge  cohort  of  patients  attending  a  tertiary  epilepsy  refer-
al  centre  who  had  undergone  MRI  at  1.5  T  and  later  at  3  T
ith  improved  head  coils.  The  aims  were  to  determine  the
ange  of  underlying  pathologies  and  to  identify  that  propor-
ion  in  whom  modern  scanner  technology  yielded  additional
ndings  and  how  these  affected  clinical  management.
ethods
he  National  Hospital  for  Neurology  and  Neurosurgery  in
onjunction  with  the  Epilepsy  Society  at  Chalfont  runs  a
arge  tertiary  referral  epilepsy  service  with  1300  new  refer-
als  for  epilepsy  and  50  undergoing  surgery  per  year.  The
pilepsy  Society  MRI  Unit  opened  in  1995  with  a  1.5  T
S
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eneral  Electric  Horizon  Echospeed  scanner  (GE  Medical  Sys-
ems,  Milwaukee,  USA)  employing  quadrature  coils.  This  was
eplaced  by  a  3  T  General  Electric  Signa  Excite  HDx  scanner
GE  Medical  Systems,  Milwaukee,  USA)  using  an  8-channel
hased  array  receive  coil  in  2004.  A  dedicated  epilepsy  pro-
ocol  MRI  acquisition  was  used  throughout  (Supplementary
ables  1  and  2).  During  the  period  1995—2010,  two  neuro-
adiologists  reported  the  scans  and  since  November  2010,  a
ingle  neuroradiologist  has  reported  the  scans.
The  MRI  database  was  queried  for  the  periods  May
995—June  2004  (16,692  bookings  for  the  1.5  T  scanner)  and
uly  2004—July  2011  (8823  bookings  for  the  3  T  scanner)  to
dentify  patients  who  had  undergone  cranial  MRI  on  the  1.5  T
canner  and  subsequently  on  the  3  T  scanner.  Scan  reports
ere  reviewed  to  determine  the  diagnosis  and  in  the  case  of
ultiple  scans  on  one  scanner  the  most  recent  diagnosis  was
sed.  Only  patients  in  whom  the  indication  for  scanning  was
pilepsy  and  with  reports  available  on  both  scanners  were
ncluded.  The  medical  notes  were  reviewed  to  determine
he  treating  clinician’s  classiﬁcation  of  the  epilepsy  (focal,
eneralised  or  unclassiﬁed).  Printed  ﬁlms  of  the  1.5  T  scans
ere  reviewed  and  the  most  recent  3  T  scans  were  reviewed
lectronically  to  identify  illustrative  cases.  The  1.5  T  elec-
ronic  data  are  no  longer  available  and  the  printed  ﬁlms
epresent  only  a  subset  of  the  sequences  acquired.
This  retrospective  evaluation  of  clinically  acquired  data
as  considered  by  the  Joint  Research  Ethics  Committee  of
he  National  Hospital  for  Neurology  and  Neurosurgery  and
nstitute  of  Neurology  to  be  audit/service  evaluation  so  indi-
idual  patient  consent  was  not  required.
esults
04  patients  who  underwent  imaging  on  both  scanners  were
dentiﬁed.  The  majority  suffered  focal  epilepsy  (697,  87%),
ith  the  remainder  either  generalised  (66,  8%)  or  unclassi-
ed  epilepsies  (41,  5%).
37%  of  the  mostly  recently  performed  3  T  scans  were  nor-
al  (37%)  and  20%  had  only  incidental  ﬁndings  (Table  1).  All
atients  with  generalised  epilepsy  were  in  this  group.  The
emainder  showed  abnormalities  (13%  hippocampal  sclero-
is  with  or  without  other  pathology,  8%  malformations  of
ortical  development,  4%  other)  or  previous  surgery  (18%,
redominantly  temporal).
A total  of  97  (12%)  new  diagnoses  were  found  with
he  3  T  scans  that  were  not  made  on  the  previous  1.5  T
cans  (Table  2).  Whilst  many  were  incidental,  they  were  ofThese  new  ﬁndings  did  affect  patient  management.
everal  patients  underwent  surgical  procedures,  including
nterior  temporal  lobe  resection,  removal  of  an  epilep-
ogenic  tuber,  gamma  knife  surgery  for  hypothalamic
The  value  of  repeat  neuroimaging  for  epilepsy  
Table  1  Diagnosis  on  most  recent  3  T  scan.
Diagnosis  Number
(percentage)
Normal  299  (37%)
Hippocampal  sclerosis  101  (13%)
Unilateral  50
Unilateral  with  dual  pathology  37
Bilateral  10
Bilateral  with  dual  pathology 4
Malformations  of  cortical  development 61  (8%)
Tuberous  sclerosis 7
Focal  cortical  dysplasia 22
Dysembryoplastic  neuroepithelial
tumour
18
Heterotopia  5
Polymicrogyria  3
Unspeciﬁed  6
Other  abnormality  36  (4%)
Cavernoma  9
Glioma  7
Meningioma  (causative)  1
Hypothalamic  hamartoma  3
Haemorrhage  2
Hydrocephalus  1
Unspeciﬁed  lesion  13
Non-speciﬁc/incidental  162  (20%)
Cerebral/cerebellar  atrophy  47
Damage  (unspeciﬁed,  predominantly
traumatic)
47
Infarct/ischaemic  damage 32
White  matter  lesions 28
Meningioma  (incidental) 3
Other  incidental 5
Post-surgical 145  (18%)
Frontal  20
Temporal  119
Parietal  4
Occipital  2
D
K
M
m
ﬁ
u
f
(
t
o
i
w
y
w
h
p
p
F
H
m
s
i
t
i
t
e
d
O
w
ﬁ
t
c
l
1
t
t
a
o
(
i
b
a
r
n
m
o
O
e
a
o
analysis  techniques  such  as  voxel-based  FLAIR  (Focke  et  al.,hamartoma  and  insertion  of  a  shunt  for  hydrocephalus
(Table  2).  Of  the  13  patients  newly  diagnosed  with  focal
cortical  dysplasia,  3  underwent  surgery,  1  underwent
intracranial  recording  but  was  unsuitable  for  resection,  2
declined  intracranial  recording,  2  are  pursuing  anti-epileptic
drugs  currently,  1  was  considered  unsuitable  and  4  are  cur-
rently  undergoing  further  presurgical  investigations.
Progression  of  the  underlying  abnormality  (e.g.  atro-
phy,  ischaemia)  was  observed  in  a  further  9  patients.  A
change  in  diagnosis  was  made  in  18  patients  and  91  patients
(11%)  had  undergone  surgery,  predominantly  temporal  (79
patients).  The  changes  in  diagnosis  were  mostly  reinter-
pretation  of  the  imaging  data  (12  patients),  for  example
from  DNET  to  glioma.  These  changes  were  histologically
conﬁrmed  in  the  two  patients  proceeding  to  surgery.  In  the
remaining  6  patients  a  previously  reported  abnormality  was
subsequently  considered  normal  (hippocampal  sclerosis  in  5
cases).  Overall  the  reports  showed  a  change  in  206  patients
(26%).
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ey  ﬁndings
agnetic  resonance  imaging  plays  a  key  role  in  the  assess-
ent  of  patients  with  epilepsy  and  in  this  study  a  relevant
nding  was  detected  in  30%  of  patients  who  had  not  already
ndergone  surgery.  This  exceeds  a  previously  reported  yield
or  relevant  abnormalities  of  18%  at  3  T  MRI  in  focal  epilepsy
Craven  et  al.,  2011),  although  referral  and  selection  bias  in
he  population  scanned  will  affect  the  yield.
Signiﬁcant  improvements  in  imaging  technology  have
ccurred  over  recent  years  and  a  number  of  factors  may
nﬂuence  the  diagnostic  yield.  The  key  ﬁnding  in  this  study
as  that  3  T  scans  with  modern  head  coils  and  gradients
ielded  a relevant  new  diagnosis  in  5%  of  those  patients
ho  had  previous  1.5  T  scans  in  the  same  centre  and  which
ad  been  reported  as  normal,  and  a  further,  smaller  pro-
ortion  had  diagnoses  clariﬁed  that  were  not  due  to  disease
rogression  between  the  two  scans.
actors  affecting  the  diagnostic  yield
igh  resolution  fast  sequences  at  1.5  T,  including  3D  volu-
etric  T1-weighted  and  T2-weighted  fast  spin  echo  (FSE)
equences  (Barkovich  et  al.,  1995)  and  ﬂuid-attenuated
nversion  recovery  (FLAIR)  imaging  improves  the  detec-
ion  of  relevant  pathology  (Bergin  et  al.,  1995) so  it  is
mportant  to  implement  a  specialist  epilepsy  imaging  pro-
ocol  (Recommendations  for  neuroimaging  of  patients  with
pilepsy,  1997;  Guidelines  for  neuroimaging,  1998).  This
etects  pathology  in  85—94%  (McBride  et  al.,  1998;  Von
ertzen  et  al.,  2002)  of  patients  with  focal  epilepsy  who
ere  MRI-negative  with  conventional  sequences  at  1.5  T.
Two  major  technical  developments  are  the  increase  in
eld  strength  from  1.5  T  to  3  T  (Alvarez-Linera,  2007)  and
he  change  in  coil  design  from  quadrature  to  phased  array
oils.  The  increased  signal  to  noise  ratio  (SNR)  from  the
atter  can  increase  diagnostic  yield  at  1.5  T  (Grant  et  al.,
998;  Goyal  et  al.,  2004) and  in  combination  with  doubling
he  ﬁeld  strength  is  estimated  to  increase  SNR  by  a  fac-
or  of  6—8  (Knake  et  al.,  2005).  This  large  increase  in  SNR
llows  faster  imaging  for  a  given  resolution,  a  higher  res-
lution  for  a  given  scan  time  or  a  combination  of  the  two
Alvarez-Linera,  2007).  Of  particular  importance  is  the  abil-
ty  to  acquire  thinner  slices  and  our  protocol  has  recently
een  extended  by  the  addition  of  3.5  mm  thick  axial  FLAIR
nd  3  mm  thick  coronal  FSE  T2  imaging.
Diagnostic  yield  can  be  further  improved  by  scans  being
ead  by  expert  neuroradiologists  working  in  concert  with
eurologists  with  expertise  in  epilepsy.  Detection  of  abnor-
alities  on  conventional  1.5  T  MRI  images  had  a  sensitivity
f  39%  with  non-experts  compared  to  50%  in  experts  (Von
ertzen  et  al.,  2002).  This  increased  further  to  91%  when
xperts  were  shown  high  resolution  studies.  However,  some
bnormalities  escape  visual  detection  even  by  experienced
bservers  and  the  introduction  of  computer-based  image008) or  surface-based  morphological  analysis  for  focal  cor-
ical  dysplasia  (Besson  et  al.,  2008;  Thesen  et  al.,  2011)  may
urther  increase  the  yield.
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Table  2  New  diagnoses  made  between  1.5  T  and  3  T  scans,  and  surgical  decision.
Diagnosis  Number  (percentage)  Surgical  decision
Hippocampal  sclerosis  13  (1.6%)
Unilateral  hippocampal  sclerosis  (HS)  10  ATLR  (2)
Bilateral  HS  (previously  unilateral  HS)  3
Malformations  of  cortical  development  19  (2.4%)
Tuberous  sclerosis  1  Tuber  resection  (1)
Focal cortical  dysplasia  13  Surgery  (3),  ICR  —  unsuitable  (1),  declined  ICR  (2),
pursuing  AED  (2),  considered  unsuitable  (1),  undergoing
further  investigation  (4)
Dysembryoplastic  neuroepithelial  tumour 4  ICR  —  unsuitable  (1),  declined  surgery  (2),  pursuing  AED
(1)
Unspeciﬁed 1  Unsuitable  (1)
Other abnormality  5  (0.6%)
Meningioma  (recurrence)  1  Seizure  free  (1)
Hypothalamic  hamartoma  1  Gamma  knife  surgery  (1)
Haemorrhage  (signiﬁcant)  1  Declined  surgery  (1)
Hydrocephalus  1  Insertion  of  shunt  (1)
Unspeciﬁed  lesion  1  ICR  —  unsuitable  (1)
Non-speciﬁc/incidental  60  (7.5%)
Cerebral/cerebellar  atrophy  22
Traumatic  damage  14
Infarct/ischaemic  damage  9
White matter  lesions  3
Meningioma  (incidental)  5
Haemorrhage  (incidental) 4
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Abbreviations: AED, antiepileptic drugs; ATLR, anterior temporal 
ocal  cortical  dysplasia
he  increased  detection  of  hippocampal  sclerosis  at  3  T  is
ikely  a  combination  of  improved  sensitivity  and  the  devel-
pment  over  time  of  this  pathology  between  the  scans,
hich  can  be  further  studied  by  T2  relaxometry  and  hip-
ocampal  volumetry  (Woermann  et  al.,  1998).  However,
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igure  1  Refractory  frontal  lobe  epilepsy  due  to  left  superior  front
obe epilepsy  from  the  age  of  12  years.  Imaging  at  1.5  T  at  the  age  of
ere suggestive  of  a  left  frontal  lobe  onset.  Subsequent  3  T  imagin
rontal sulcus  (B)  despite  the  movement  artefact.  Images  are  corona
urgery resulted  in  seizure  freedom  with  histology  conﬁrming  focal  cresection; ICR, intracranial EEG recording.
alformations  of  cortical  development  are  likely  to  have
een  present  throughout  and  the  increased  detection
f  focal  cortical  dysplasia  (FCD)  represents  a  signiﬁcant
dvance  which  deserves  special  mention.  The  correct  iden-
iﬁcation  of  FCD  is  challenging.  In  a  retrospective  series  of
athologically  proven  FCD,  the  MRI  was  reported  as  normal
n  34%  (Tassi  et  al.,  2002).  Standard  imaging  fails  to  identify
al  sulcus  focal  cortical  dysplasia.  Patient  with  refractory  frontal
 20  in  2002  was  reported  as  normal  (A),  but  EEG  and  ictal  SPECT
g  in  2009  revealed  focal  cortical  dysplasia  of  the  left  superior
l  FLAIR  images  at  the  level  of  the  posterior  thalami.  Resective
ortical  dysplasia  type  IIb.
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Figure  2  Refractory  partial  epilepsy  with  right  inferior  parietal  malformation  of  cortical  development.  Patient  with  refractory
partial epilepsy  and  learning  disability.  Imaging  in  2001  at  1.5  T  was  reported  as  normal  (A)  but  subsequent  imaging  in  2004  at  3  T
rtica
I
r
v
a
ﬁ
s
o
s
s
prevealed an  extensive  right  inferior  parietal  malformation  of  co
the posterior  edge  of  the  occipital  horns.
FCD  in  up  to  80%  of  patients  when  the  abnormality  lies  in  the
depth  of  a  sulcus  (Besson  et  al.,  2008).  The  improved  SNR
at  3  T  improves  the  detection  of  focal  abnormalities  such
as  FCD  through  better  deﬁnition  of  the  grey/white  matter
junction  (which  becomes  blurred  in  FCD)  and  a  more  uniform
signal  intensity  in  normal  cortex  (in  contrast  to  hyperintense
signal  within  the  dysplastic  region).
Previous  studies
Two  studies  have  compared  1.5  T  and  3  T  scans  in  patients
with  epilepsy  and  reached  contradictory  conclusions.  In  the
ﬁrst  a  series  of  40  patients  undergoing  presurgical  evaluation
underwent  scans  on  a  Siemens  3  T  scanner  at  a  special-
ist  centre  with  phased  array  coils  (Knake  et  al.,  2005).
f
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(
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Figure  3  Complex  motor  seizures  due  to  a  hypothalamic  hamartom
Imaging at  1.5  T  at  the  age  of  22  years  in  2001  was  reported  as  norm
on 3  T  imaging  in  2011  (B).  Image  A  is  coronal  T2-weighted  images  at
B is  a  coronal  oblique  PROPELLER  (periodically  rotated  overlapping  p
seizures were  identiﬁed  in  hindsight  and  the  patient  has  undergone  l  development  (B).  Images  are  coronal  T2-weighted  images  at
n  comparison  to  prior  standard  1.5  T  MRI  performed  and
eported  elsewhere,  lesions  were  detected  in  65%  of  pre-
iously  MRI  negative  patients  and  clinical  management  was
ffected  in  38%.  However,  four  variables  were  different  —
eld  strength,  availability  of  a  phased  array  coil,  use  of  a
pecialist  epilepsy  protocol  and  reporting  by  an  experienced
bserver.  Given  these  numerous  differences  and  the  inclu-
ion  of  only  patients  being  considered  for  surgery,  it  is  not
urprising  that  there  was  a  higher  yield  of  new  diagnoses  in
reviously  MRI-negative  patients.
The  second  study  included  37  patients  being  consideredor  surgery  who  were  scanned  on  1.5  T  and  3  T  scanners  both
sing  phased  array  coils  and  reported  by  the  same  observers
Zijlmans  et  al.,  2009).  Thus  there  were  fewer  technical  dif-
erences  between  the  scans.  This  in  conjunction  with  the
a.  Patient  with  complex  motor  seizures  from  the  age  of  2  years.
al  (A)  with  the  hypothalamic  hamartoma  only  being  identiﬁed
 the  level  of  mammillary  bodies  and  temporal  stems  and  image
arallel  lines  with  enhanced  reconstruction)  sequence.  Gelastic
gamma  knife  surgery.
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election  of  only  patients  considered  ineligible  for  surgery
ollowing  1.5  T  scans  might  explain  the  failure  to  demon-
trate  increased  yield  at  3  T.  Whilst  dysplasia  was  detected
ore  frequently,  hippocampal  sclerosis  was  reported  less
ften.
trengths  and  limitations
n  the  context  of  limited  and  contradictory  previous  litera-
ure,  the  present  study  represents  the  largest  comparison
f  repeat  imaging  in  patients  with  epilepsy  at  a  tertiary
eferral  centre  over  a  period  of  16  years.  It  is  not  possi-
le  to  disentangle  the  relative  contributions  to  diagnostic
ield  of  an  increase  in  ﬁeld  strength  from  the  introduction  of
hased  array  coils  (used  on  the  3  T  scanner,  but  not  the  1.5  T
canner).  However,  it  is  not  feasible  to  apply  a  prospective
tudy  to  such  a  large  cohort  with  the  previous  studies  only
ssessing  37  (Zijlmans  et  al.,  2009)  or  40  patients  (Knake
t  al.,  2005).
The  particular  strengths  of  the  current  study  are  the
ize  of  the  cohort,  the  use  of  dedicated  epilepsy  protocols
hroughout  and  the  scan  reporting  by  experienced  neurora-
iologists,  with  the  majority  of  scans  at  both  ﬁeld  strengths
eing  reported  by  the  same  two  observers.
In  the  current  study,  the  scans  were  clinically  reported
ith  knowledge  of  the  clinical  details,  rather  than  blind,
nd  only  the  scan  reports  rather  than  the  imaging  itself
ere  reviewed  for  this  study.  In  some  cases  it  may  be  pos-
ible  in  hindsight  to  identify  a  lesion  only  identiﬁed  with
he  3  T  scan  on  the  earlier  1.5  T  scan.  However,  this  does
ot  represent  clinical  practice  and  the  full  1.5  T  imaging
ata  from  the  1990s  are  not  available  for  review.  This
hance  is  minimised  by  the  use  of  the  same  two  experi-
nced  neuroradiologists  for  the  majority  of  the  reporting
eriod  and  many  of  the  new  diagnoses  obtained  were  those
hat  theoretically  beneﬁt  from  the  improved  scan  technol-
gy.  Finally,  some  selection  bias  may  have  been  introduced
s  those  having  repeated  scans  may  be  more  likely  to  have
een  previously  MRI  negative  and  to  have  epilepsy  that
ad  not  gone  into  remission,  and  thus  be  biased  to  those
ith  a  higher  likelihood  of  structural  pathology  than  those
ho  remitted  and  who  would  thus  be  less  likely  to  be  res-
anned.
onclusions
n  conclusion,  this  is  the  largest  study  of  a  cohort  of  patients
ith  epilepsy  undergoing  MRI  at  1.5  T  and  subsequently
t  3  T  with  improved  head  coils  with  both  employing  a
pecialist  epilepsy  protocol  at  a  tertiary  referral  centre.
 T  MRI  identiﬁed  a  relevant  abnormality  in  around  30%
atients  who  had  not  already  undergone  surgery.  In  5%  of
atients,  a  relevant  diagnosis  was  reached  with  the  3  T
can  which  had  not  been  reported  on  the  previous  1.5  T
can.  The  new  information  contributed  to  clinical  man-
gement,  particularly  in  the  detection  of  focal  cortical
ysplasia.
The  yield  of  diagnostic  imaging  is  dependent  upon  many
actors,  including  high  resolution  sequences,  magnetic  ﬁeld
trength,  phased  array  coils,  gradient  performance,  a  spe-
ialist  epilepsy  protocol  and  dedicated  neuroradiologists  and
GG.P.  Winston  et  al.
ay  be  increased  further  by  the  introduction  of  computer-
ased  analysis  techniques.  The  point  of  practical  importance
s  to  rescan  individuals  with  previously  unclear  MRI  using
ptimal  technology.
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